Viewing Study NCT06249932

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:58 PM
Ignite Modification Date: 2026-01-03 @ 6:00 AM
Study NCT ID: NCT06249932
Status: RECRUITING
Last Update Posted: 2024-12-13
First Post: 2024-01-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease
Sponsor: National Taiwan University Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Heart Failure with Reduced Ejection Fraction View
None End Stage Renal Disease on Dialysis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None end stage renal disease View
None sodium-glucose co-transporter 2 inhibitors, View
None heart failure with reduced ejection fraction View
None empagliflozin View
None left ventricular mass View